Nannospalax galili (Upper Galilee mountains blind mole rat)

Summary
Taxonomy ID
1026970
PubChem Taxonomy
1026970
Displaying entries 1 - 25 of 70 in total
UniProt ID Protein Name Gene Symbol No. of Glycosylation Sites ▼ No. of GlyTouCan IDs Disease Ontology
A0A8C6R1B2 Angiotensin-converting enzyme
  • LOC103744762
13 0
A0A8C6RKW2 Fibroblast growth factor receptor
  • Fgfr1
8 0
A0A8C6RDM0 Fibroblast growth factor receptor
  • Fgfr2
8 0
A0A8C6RDT8 Fibroblast growth factor receptor
  • Fgfr2
8 0
A0A8C6R1G7 Angiotensin-converting enzyme
  • LOC103744762
6 0
A0A8C6RGZ5 N-acylethanolamine-hydrolyzing acid amidase
  • Naaa
4 0
A0A8C6WA93 ADAM metallopeptidase with thrombospondin type 1 motif 1
  • Adamts1
3 0
A0A8C6QPB5 Prothrombin
  • F2
3 0
A0A8C6RG46 Angiotensin-converting enzyme
  • Ace2
3 0
A0A8C6S0Z5 Paraoxonase
  • Pon1
3 0
Q6H8S9 Erythropoietin
  • EPO
3 0
A0A8C6QS27 Prothrombin
  • F2
3 0
A0A8C6RNU2 Beta-secretase 2
  • Bace2
2 0
A0A8C6RPB0 ADAM metallopeptidase with thrombospondin type 1 motif 5
  • Adamts5
2 0
A0A8C6RT85 Cathepsin D
  • Ctsd
2 0
A0A8C6W671 Paraoxonase
  • Pon2
2 0
A0A8C6RQS0 Rhodopsin
  • Rho
2 0
A0A8C6RU96 Cathepsin D
  • Ctsd
2 0
A0A8C6RV77 GDNF family receptor alpha-2
  • Gfra2
2 0
A0A8C6RSY3 Phosphoinositide phospholipase C
  • Plcd1
2 0
A0A8C6RSU1 Paraoxonase
  • Pon3
2 0
A0A8C6RAY2 GDNF family receptor alpha-1
  • Gfra1
2 0
A0A8C6RCA2 GDNF family receptor alpha-1
  • Gfra1
2 0
A0A8C6QIZ5 Potassium channel subfamily K member
  • Kcnk7
1 0
A0A8C6QJP4 Potassium channel subfamily K member
  • Kcnk7
1 0

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024